MED19 Antikörper (AA 51-150) (HRP)
Kurzübersicht für MED19 Antikörper (AA 51-150) (HRP) (ABIN6987615)
Target
Alle MED19 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 51-150
-
Kreuzreaktivität
- Ratte
-
Homologie
- Human,Mouse,Cow,Horse,Chicken
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human MED19/LCMR1
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IHC-P 1:200-400
IHC-F 1:100-500 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- MED19 (Mediator Complex Subunit 19 (MED19))
-
Andere Bezeichnung
- MED19
-
Hintergrund
-
Synonyms: LCMR1, Lung cancer metastasis related protein 1, Lung cancer metastasis-related protein 1, med19, MED19_HUMAN, Mediator complex subunit 19, Mediator of RNA polymerase II transcription subunit 19, Mediator of RNA polymerase II transcription, subunit 19 homolog.
Background: MED19 is a component of the Mediator complex, which is a coactivator for DNA-binding factors that activate transcription via RNA polymerase II (Sato et al., 2003 [PubMed 12584197]).[supplied by OMIM, Oct 2008]
-
Gen-ID
- 219541
-
UniProt
- A0JLT2
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha
Target
-